Evidence map›Paper›PMID 32060111›Full record

ArticleBMJ case reports2020

Primary cutaneous

Pradeep Kumar Mada, Daniel Alexander Saldaña Koppel, Majd Al Shaarani, Andrew Stevenson Joel Chandranesan

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Primary Cutaneous Aspergillosis Due toInfection and drug resistance · 2023
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Pradeep Kumar MadaInfectious Diseases, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA pradeepsomc@gmail.com.ORCID http://orcid.org/0000-0001-7855-7982
Daniel Alexander Saldaña KoppelInternal Medicine, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.
Majd Al ShaaraniAnatomic & Clinical Pathology, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.
Andrew Stevenson Joel ChandranesanInfectious Diseases, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.
Louisiana State University Health Sciences Center Shreveport · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary cutaneous aspergillosis (PCA) occurs through inoculation of fungal spores directly into the skin from the environment through disrupted skin such as in burns, surgery or penetrating trauma patients. Most cases reported in literature were in the immunocompromised, rarely in immunocompetent patients. The characteristic lesion of cutaneous aspergillosis is a black eschar on a red plaque, or nodule at the site of skin injury. The diagnosis of PCA can be made by identifying hyphal forms on routine H&E staining or special stains such as periodic acid-Schiff or Gomori methenamine-silver stains on skin biopsy and by fungal cultures. We report a case of an 80-year-old farmer who developed cutaneous aspergillosis after a surgical procedure without any systemic spread. The diagnosis was made by histopathology and tissue fungal cultures. He was treated with incision and drainage followed by oral voriconazole for 4 weeks; which led to clinical recovery.

Indexed as

Aged, 80 and overAspergillosisAspergillus fumigatusDermatomycosesHumansImmunocompetenceMalePostoperative ComplicationsStaining and LabelingVoriconazoleVoriconazoledermatologicaldrugs: infectious diseasesexposurespathologyskin

Identifiers

PMID32060111
PMCPMC7046428
OpenAlexW3006204956

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.